Beam Therapeutics (BEAM) Other Operating Expenses (2019 - 2021)
Historic Other Operating Expenses for Beam Therapeutics (BEAM) over the last 3 years, with Q1 2021 value amounting to -$1.2 million.
- Beam Therapeutics' Other Operating Expenses rose 4355.68% to -$1.2 million in Q1 2021 from the same period last year, while for Dec 2021 it was -$1.2 million, marking a year-over-year increase of 9808.03%. This contributed to the annual value of -$61.8 million for FY2020, which is 184930.64% down from last year.
- Latest data reveals that Beam Therapeutics reported Other Operating Expenses of -$1.2 million as of Q1 2021, which was up 4355.68% from -$54.7 million recorded in Q4 2020.
- In the past 5 years, Beam Therapeutics' Other Operating Expenses ranged from a high of $2.9 million in Q3 2020 and a low of -$54.7 million during Q4 2020
- Over the past 3 years, Beam Therapeutics' median Other Operating Expenses value was -$1.3 million (recorded in 2019), while the average stood at -$8.2 million.
- Over the last 5 years, Beam Therapeutics' Other Operating Expenses had its largest YoY gain of 39245.67% in 2020, and its largest YoY loss of 367761.9% in 2020.
- Beam Therapeutics' Other Operating Expenses (Quarter) stood at -$1.5 million in 2019, then tumbled by 3596.08% to -$54.7 million in 2020, then skyrocketed by 97.83% to -$1.2 million in 2021.
- Its Other Operating Expenses was -$1.2 million in Q1 2021, compared to -$54.7 million in Q4 2020 and $2.9 million in Q3 2020.